- Home
- PUBM vs TNGX Comparison
PUBM vs TNGX Comparison
Compare PUBM & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUBM
- TNGX
- Stock Information
- Founded
- PUBM 2006
- TNGX 2014
- Country
- PUBM United States
- TNGX United States
- Employees
- PUBM N/A
- TNGX N/A
- Industry
- PUBM Computer Software: Prepackaged Software
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- PUBM Technology
- TNGX Health Care
- Exchange
- PUBM Nasdaq
- TNGX Nasdaq
- Market Cap
- PUBM 732.4M
- TNGX 735.0M
- IPO Year
- PUBM 2020
- TNGX N/A
- Fundamental
- Price
- PUBM $15.30
- TNGX $7.00
- Analyst Decision
- PUBM Buy
- TNGX Strong Buy
- Analyst Count
- PUBM 7
- TNGX 8
- Target Price
- PUBM $21.17
- TNGX $15.14
- AVG Volume (30 Days)
- PUBM 332.8K
- TNGX 987.3K
- Earning Date
- PUBM 11-12-2024
- TNGX 11-06-2024
- Dividend Yield
- PUBM N/A
- TNGX N/A
- EPS Growth
- PUBM 351.34
- TNGX N/A
- EPS
- PUBM 0.36
- TNGX N/A
- Revenue
- PUBM $282,245,000.00
- TNGX $42,509,000.00
- Revenue This Year
- PUBM $10.76
- TNGX $18.15
- Revenue Next Year
- PUBM $9.74
- TNGX N/A
- P/E Ratio
- PUBM $41.17
- TNGX N/A
- Revenue Growth
- PUBM 9.60
- TNGX 26.16
- 52 Week Low
- PUBM $10.92
- TNGX $6.33
- 52 Week High
- PUBM $25.36
- TNGX $13.01
- Technical
- Relative Strength Index (RSI)
- PUBM 55.82
- TNGX 38.89
- Support Level
- PUBM $14.55
- TNGX $6.75
- Resistance Level
- PUBM $15.50
- TNGX $7.31
- Average True Range (ATR)
- PUBM 0.43
- TNGX 0.34
- MACD
- PUBM 0.14
- TNGX 0.10
- Stochastic Oscillator
- PUBM 84.44
- TNGX 46.21
About PUBM PubMatic Inc.
PubMatic is one of the leading supply-side platform providers in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, better manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). PubMatic generates revenue mainly via taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Given the growth in overall digital advertising, more publishers and advertisers are adopting programmatic (or automated) buying and selling, driving the firm's success in attracting more inventory.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.